Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study
ACCES
1 other identifier
observational
69
1 country
1
Brief Summary
The aim of this study is to implement a simple and unsupervised home-based physical activity (PA) program for cancer patients in 2 oncogeriatric units in Toulouse Hospital (day hospital and week hospital).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2023
CompletedFirst Posted
Study publicly available on registry
October 26, 2023
CompletedStudy Start
First participant enrolled
November 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedApril 10, 2025
April 1, 2025
1.9 years
October 20, 2023
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility of the PA program
PA program is considered feasible if at least 50% of them complete at least 70% of the prescribed sessions. Adherence is recorded in a logbook (every day), during the usual follow-up at the hospital (every month) and during telephone follow-up (weeks 1, 2, 4, 6, 9, 12, 16, 20, et 24).
6 months
Interventions
The PA program is specific for each patient according to their mobility profile assessed using a decision tree comprising 3 tests: 1) the number of repetitions in the 30-second sit-to-stand test, 2) the score in the Short Physical Performance Battery (SPPB) test and 3) grip strength. The PA program has to be performed once daily.
Eligibility Criteria
geriatric population suffering from a hematological malignancy (Myelodysplasia, Leukemia of any type, Lymphoma, Myeloma
You may qualify if:
- suffering from a hematological malignancy (Myelodysplasia, Leukemia of any type, Lymphoma, Myeloma)
- patient affiliated to a social security insurance
- Patient undergoing or scheduled chemotherapy (\< 3 months) and/or immunotherapy and/or targeted therapy.
You may not qualify if:
- Life expectancy estimated at less than 3 months by the unit doctor;
- Cognitive impairment (not allowing comprehension of the physical activity program and research project) defined by Mini-Mental State Examination (MMSE) \<20/30;
- Patient included in a clinical trial that potentially interferes with the study objective (geriatric interventional study, early drug study, study modifying the patient's lifestyle habits).;
- Acute health problem (fever, severe anemia, intense pain, etc.) limiting the possibility of involvement in the program;
- Contraindication to physical activity;
- Patient under legal protection (guardianship or curatorship or safeguard of justice);
- Refusal of patient or primary caregiver to participate.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu de Toulouse
Toulouse, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yves Rolland
University Hospital, Toulouse
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2023
First Posted
October 26, 2023
Study Start
November 14, 2023
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
April 10, 2025
Record last verified: 2025-04